A little more than a year after its approval, Adapt Pharma made the case for the effectiveness of its Narcan (naoloxone) Nasal Spray 4 mg at the annual American Academy of Pain Medicine in Orlando.
Product intended to work well for diabetics by soothing and protecting after puncture, and last for approximately three months.
Egalet said Arymo ER is the first drug approved using its proprietary Guardian Technology, which works to deter abuse and prevent the tablets from being manipulated for abuse or misuse.
NCPA addressed several areas where independent community pharmacies and the patients they serve could be adversely affected by the pharmacy “lock-in” provision in the opioid abuse legislation.
Prime said there were 20.5 million opioid claims in the time period between Jan. 1, 2014 and March 31, 2016.
There's a new reusable applicator that freezes injection sites to reduce pain and discomfort, and it's targeted specifically at people with diabetes.
Among the changes, the FDA is requiring boxed warnings for nearly 400 products, as well as patient-focused Medication Guides for prescription opioids and benzodiazepines.